Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

48.53
Delayed Data
As of Jun 27
 -1.48 / -2.96%
Today’s Change
48.01
Today|||52-Week Range
72.31
-26.07%
Year-to-Date
Teva's Cinqaero Gets Positive CHMP View, Decision in 2H16
Jun 27 / Zacks.com - Paid Partner Content
Is Opko Health a Buy Now That Rayaldee Is Approved?
Jun 21 / MotleyFool.com - Paid Partner Content
Allergan (AGN) Gets FDA Nod for Avycaz Label Expansion
Jun 24 / Zacks.com - Paid Partner Content
What Exactly Did Allergan and Teva Sell to Impax?
Jun 21 / TheStreet.com - Paid Partner Content
AstraZeneca, Teva Resolve Their Patent Row Over Diabetes Product
Jun 23 / TheStreet.com - Paid Partner Content
Here's Why Alphabet, Allergan and L Brands Will Take Off in Second Half
Jun 21 / TheStreet.com - Paid Partner Content
Impax (IPXL) Stock Declines on Deal to Buy Generic Products
Jun 22 / Zacks.com - Paid Partner Content
Why Is Impax Labs Tumbling 11.7% Today
Jun 21 / MotleyFool.com - Paid Partner Content
'Mad Money' Lightning Round: Be Patient on Alcoa
Jun 22 / TheStreet.com - Paid Partner Content
3 High-Growth Stocks You Don't Need to Babysit
Jun 17 / MotleyFool.com - Paid Partner Content